GSK rolls out its Shingles vaccine in India

The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilitating pain and rashes caused by the reactivation of the varicella zoster virus (VZV). VZV is the same virus that causes chickenpox.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news